−0.0192 SEK
−42.59 M SEK
37.12 M SEK
About PEPTONIC MEDICAL AB
Sector
CEO
Erik Sundquist
Headquarters
Bromma
Website
Founded
2009
ISIN
SE0005962206
FIGI
BBG006K9QLS9
Peptonic Medical AB engages in the development of oxytocin based products for the treatment of menopausal symptoms. It develops Vagitocin, which focuses on the treatment of vaginal atrophy. The company was founded by Kerstin Uvnas Moberg and Ronald Eric Long on December 2, 2008 and is headquartered in Bromma, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PMED is 0.0038 SEK — it has decreased by −5.00% in the past 24 hours. Watch PEPTONIC MEDICAL AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange PEPTONIC MEDICAL AB stocks are traded under the ticker PMED.
PMED stock has fallen by −13.64% compared to the previous week, the month change is a −5.00% fall, over the last year PEPTONIC MEDICAL AB has showed a −92.83% decrease.
PMED reached its all-time high on Jul 29, 2015 with the price of 8.4010 SEK, and its all-time low was 0.0032 SEK and was reached on Nov 29, 2024. View more price dynamics on PMED chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PMED stock is 17.65% volatile and has beta coefficient of 1.09. Track PEPTONIC MEDICAL AB stock price on the chart and check out the list of the most volatile stocks — is PEPTONIC MEDICAL AB there?
Today PEPTONIC MEDICAL AB has the market capitalization of 21.89 M, it has decreased by −4.76% over the last week.
Yes, you can track PEPTONIC MEDICAL AB financials in yearly and quarterly reports right on TradingView.
PMED net income for the last quarter is −11.13 M SEK, while the quarter before that showed −11.51 M SEK of net income which accounts for 3.29% change. Track more PEPTONIC MEDICAL AB financial stats to get the full picture.
No, PMED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 37.00 employees. See our rating of the largest employees — is PEPTONIC MEDICAL AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PEPTONIC MEDICAL AB EBITDA is −42.15 M SEK, and current EBITDA margin is −96.94%. See more stats in PEPTONIC MEDICAL AB financial statements.
Like other stocks, PMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PEPTONIC MEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PEPTONIC MEDICAL AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PEPTONIC MEDICAL AB stock shows the sell signal. See more of PEPTONIC MEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.